SCHEMBL23965933

SCHEMBL23965933

CCn1c(NC(=O)c2cnc(N)nc2)nc2c(OC)c(OCCN3CCC4(CC3)CC4)ccc2c1=O

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PIK3CB P42338 6/20 0.43
PIK3CD O00329 2/20 0.43
PIK3CA P42336 2/20 0.43
PIK3CG P48736 2/20 0.43
CHRM2 P08172 1/20 0.43
PIK3R1 P27986 1/20 0.43
MTOR P42345 1/20 0.43
RAB27A P51159 1/20 0.43
KMT2A Q03164 1/20 0.34
KDR P35968 3/20 0.33
PIK3C2A O00443 1/20 0.33
EGFR P00533 1/20 0.33
MCHR1 Q99705 3/20 0.33
OPRK1 P41145 1/20 0.33
CNR2 P34972 1/20 0.33
HSP90AB1 P08238 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22163855 0.95 PIK3CB (0.42) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL23966005 0.94 PIK3CB (0.44) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL23966062 0.94 PIK3CB (0.43) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL24211258 0.94 PIK3CB (0.41) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL24211091 0.92 PIK3CB (0.45) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL23966130 0.92 PIK3CB (0.44) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL23966016 0.92 PIK3CB (0.45) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL23966057 0.92 PIK3CB (0.45) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL23966129 0.91 PIK3CB (0.41) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2
SCHEMBL23966018 0.89 PIK3CB (0.49) PIK3CBPIK3CDPIK3CAPIK3CGCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017505-A1 AMINOQUINAZOLINONE AND AMINOISOQUINOLINONE DERIVATIVES AND APPLICATION THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2022-01-20 US disclosed
EP-3904343-A1 AMINO QUINAZOLINONE, AMINO ISOQUINOLONE DERIVATIVES AND APPLICATION THEREOF Zhejiang University (CN) 2021-11-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220017505-A1 AMINOQUINAZOLINONE AND AMINOISOQUINOLINONE DERIVATIVES AND APPLICATION THEREOF PIK3R5, PIK3CA, PIK3R1 PIK3CB 9/4885PIK3CD 4/4885PIK3CA 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.